Bio Protocol vs SuperVerse — how do they compare? Bio Protocol trades at Rp432.87 (market cap Rp983,84M, Rp162,92M 24h volume), while SuperVerse trades at Rp1,485 (market cap Rp955,61M, Rp36,04M 24h volume). The key difference: Bio Protocol and SuperVerse are close in size by market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 640,2M / 1.000M SUPER (65%) for SuperVerse. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and SuperVerse for 28 Days on average.
| BIO | SUPER | |
|---|---|---|
Market Cap | Rp983,84M | Rp955,61M |
Volume (24h) | Rp162,92M | Rp36,04M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 640,2M / 1.000M SUPER (65%) |
Typical Hold Time | 18 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
SuperVerse (SUPER) is currently trading at Rp1,516 with a market cap of Rp973.82 million, showing bearish technical signals from moving averages while oscillators remain neutral. The token trades near its pivot point of Rp1,520 with support at Rp1,465 and resistance at Rp1,554. With 64% of the maximum 1 billion token supply in circulation and average hold time of 28 days, the project shows moderate network participation.
Overall outlook remains cautious with technical weakness but neutral momentum indicators. Key opportunities include potential bounce from support levels, while risks include continued bearish pressure and limited liquidity. Investors should monitor volume patterns and ecosystem developments closely.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →SuperVerse is a cross-chain decentralized finance (DeFi) protocol built to facilitate the launching of new non-fungible tokens (NFTs) without the need for programming. A marketplace and an innovative set of tools allow any project to deploy a farm with its own rules. The SUPER token gives users access to a range of opportunities in the crypto space through SUPERVERSE, Partner Video Games and frequent NFT drops.
Read more on SUPER →